Loading...
XSHE
000623
Market cap3.23bUSD
Dec 05, Last price  
19.49CNY
1D
1.19%
1Q
1.35%
Jan 2017
-18.25%
Name

Jilin Aodong Pharmaceutical Group Co Ltd

Chart & Performance

D1W1MN
XSHE:000623 chart
P/E
14.73
P/S
8.75
EPS
1.32
Div Yield, %
3.08%
Shrs. gr., 5y
-1.66%
Rev. gr., 5y
-3.31%
Revenues
2.61b
-24.31%
767,321,745770,228,862845,146,602927,821,7911,025,515,4981,113,327,7671,145,230,6671,445,463,1701,956,861,1712,240,099,3442,334,760,8372,736,697,0772,976,771,6443,324,078,2653,088,379,5912,251,650,9502,303,763,7632,868,211,4643,449,123,3012,610,575,103
Net income
1.55b
+6.27%
110,522,797387,923,0301,992,259,763861,607,7961,366,488,9811,237,656,4651,982,049,203646,417,2061,058,789,4021,410,692,5452,593,589,3161,666,491,3611,863,471,361935,187,8931,403,640,3131,708,876,0521,780,500,3671,780,801,3451,459,879,6781,551,393,070
CFO
59m
-12.60%
136,255,140187,992,627384,693,029235,027,833213,027,240174,221,772108,303,405272,401,616201,217,819288,827,750388,032,364333,812,958256,485,969347,635,221379,456,901390,408,759324,846,060423,856,81568,060,61359,483,507
Dividend
Jul 09, 20240.6 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Jilin Aodong Pharmaceutical Group Co., Ltd. produces and sells pharmaceutical products in China. The company offers various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It also engages in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat and water; wholesale, retail, and distribution of medicines; packaging design and printing activities; production and sale of medicinal packaging materials; and information consulting and advertising design activities. The company was founded in 1957 and is headquartered in Dunhua, China.
IPO date
Oct 28, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT